Sotera Health Company
SHC
Category
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 30.93 | -64.51% |
| 2024 | 87.13 | -5.46% |
| 2023 | 92.16 | -1,022.62% |
| 2022 | -9.99 | -117.76% |
| 2021 | 56.26 | -127.95% |
| 2020 | -201.27 | -41.22% |
| 2019 | -342.40 | -67.47% |
| 2018 | -1.05K | 0.00% |
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 36.15 | 16.91% |
US
|
|
| 39.77 | 28.61% |
US
|
|
| -290.26 | -1,038.55% |
US
|
|
| - | - |
CN
|
|
| 34.18 | 10.54% |
US
|
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.